ABVC BioPharma, Inc. (ABVC)
1.08
+0.01
(+0.93%)
USD |
NASDAQ |
Sep 16, 16:00
1.09
+0.01
(+0.93%)
After-Hours: 20:00
ABVC BioPharma Total Return Level : 1.08 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 1.08 |
| September 15, 2026 | 1.07 |
| September 14, 2026 | 1.00 |
| September 11, 2026 | 0.9801 |
| September 10, 2026 | 0.9762 |
| September 09, 2026 | 0.97 |
| September 08, 2026 | 1.06 |
| September 04, 2026 | 0.9601 |
| September 03, 2026 | 1.00 |
| September 02, 2026 | 0.8645 |
| September 01, 2026 | 0.8254 |
| August 31, 2026 | 0.8575 |
| August 28, 2026 | 0.83 |
| August 27, 2026 | 0.7957 |
| August 26, 2026 | 0.711 |
| August 25, 2026 | 0.7999 |
| August 24, 2026 | 0.84 |
| August 21, 2026 | 0.8982 |
| August 20, 2026 | 0.8982 |
| August 19, 2026 | 0.9451 |
| August 18, 2026 | 0.8742 |
| August 17, 2026 | 0.8578 |
| August 14, 2026 | 0.9083 |
| August 13, 2026 | 0.9683 |
| August 12, 2026 | 0.9691 |
| Date | Value |
|---|---|
| August 11, 2026 | 0.9942 |
| August 10, 2026 | 0.959 |
| August 07, 2026 | 1.030 |
| August 06, 2026 | 1.030 |
| August 05, 2026 | 1.019 |
| August 04, 2026 | 1.08 |
| August 03, 2026 | 1.050 |
| July 31, 2026 | 1.019 |
| July 30, 2026 | 1.090 |
| July 29, 2026 | 1.019 |
| July 28, 2026 | 1.070 |
| July 27, 2026 | 1.030 |
| July 24, 2026 | 1.161 |
| July 23, 2026 | 1.211 |
| July 22, 2026 | 1.191 |
| July 21, 2026 | 1.242 |
| July 20, 2026 | 1.211 |
| July 17, 2026 | 1.262 |
| July 16, 2026 | 1.221 |
| July 15, 2026 | 1.292 |
| July 14, 2026 | 1.352 |
| July 13, 2026 | 1.363 |
| July 10, 2026 | 1.524 |
| July 09, 2026 | 1.464 |
| July 08, 2026 | 2.039 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Anika Therapeutics, Inc. | 20.84 |
| Perspective Therapeutics, Inc. | 2.70 |
| MiMedx Group, Inc. | 4.73 |
| Abbott Laboratories | 229.48 |
| AngioDynamics, Inc. | 15.46 |